Introducing Apollo, the automated, high sensitivity, protein structural characterisation tool  

Apollo provides ultra-sensitive, ultra-precise measurements of the structure of biomolecules through a novel technology called Microfluidic Modulation Spectroscopy (MMS), now even more rapidly, with less sample volume, and with improved software and analytics features.   MMS overcomes many of the limitations of existing technologies in a typical biophysical characterisation toolkit with ultra-sensitive and highly reproducible structural measurements of proteins and other biomolecules. Users are able to compare higher-order structure and similarity profiles for confidence in structural similarity and activity to inform discovery, screening, formulation, and quality control in biopharmaceutical drug development. It can be used for a wide range of biomolecules from mAb-based biotherapeutics to robust measurements of ADCs, AAVs, and mRNA. Key features and benefits of Apollo include:   Accurate and reproducible measurements with broad concentration range from 0.1 mg/ml to >200 mg/ml allows measurements in native conditions 20x faster and 30x more sensitive to changes in structure than CD or FTIR Real-time buffer subtraction minimises background noise and interference from excipients Dramatically reduced sample volume requirements    READ MORE HERE   Get your brochure – click here Learn more about Apollo and the benefits of adding MMS into your biophysical characterisation toolkit.    30 Minute Webinar: Register here Webinar will present the features and benefits of Apollo,  May 24 2022   Register for webinar- click here In this webinar, learn how this fully-automated IR technology, generates high-quality, reproducible secondary structure data for protein therapeutics, including monoclonal antibodies. June,10 2022

Request a personal demo Request a quote now Email us for more info